# Foushee Introduces Anesthetic Gas Tax Credits

On October 9, 2026, Congresswoman Valerie Foushee introduced the Low Emission Anesthetics Act, which would establish escalating tax credits for healthcare facilities that phase out higher-emission anesthetic gases, including desflurane and nitrous oxide. The proposal is not enacted and does not create a procurement solicitation or mandatory purchasing requirement. If passed, it could affect facilities’ choices among anesthetic gases and create potential market opportunities for suppliers of lower-emission alternatives such as isoflurane and sevoflurane.

- Healthcare procurement teams can assess the operational implications of substituting lower-emission gases, including the availability of isoflurane and sevoflurane, without treating the proposed incentives as current requirements.
- Suppliers of lower-emission anesthetic alternatives may find the proposed tax credits relevant to future customer demand, but eligibility and incentive details depend on legislative progress.
- The bill’s introduction gives facilities and suppliers a concrete proposal to evaluate; the source identifies no contract opportunity, funding amount, or implementation deadline.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Policy
**Published:** October 10, 2026

### Government Entities
- U.S. House of Representatives (U.S. House)
- Congress

### Key Quotes
> Moving away from anesthetic gases that have an outsized impact on greenhouse gas emission while viable alternatives already exist in the market is one small step we can take to be better environmental stewards.
> — Valerie Foushee, Congresswoman

### Sources
- [Rep. Foushee Introduces Legislation to Promote Use of Low-Emission Anesthetic Gases | U.S. Congresswoman Valerie Foushee](https://foushee.house.gov/media/press-releases/rep-foushee-introduces-legislation-to-promote-use-of-low-emission-anesthetic-gases) - Foushee House